|1.||Ohnuki, T: 1 article (01/2001)|
|2.||Hosohata, Y: 1 article (01/2001)|
|3.||Suzuki, J: 1 article (01/2001)|
|4.||Hattori, K: 1 article (01/2001)|
|5.||Ishiguro, M: 1 article (01/2001)|
|6.||Nakamura, T: 1 article (01/2001)|
|7.||Nagatomo, T: 1 article (01/2001)|
|1.||Hypertension (High Blood Pressure)
04/22/1991 - "Bopindolol is a very useful drug of first choice in mild and moderate hypertension. "
08/01/1990 - "The objective of the study was to investigate the efficacy of different dose levels of bopindolol monotherapy in hypertension. "
04/01/1990 - "A open study with increasing doses of bopindolol, a nonselective beta-blocker of long half-life has been carried out in patients with mild and moderate hypertension in order to assess the efficacy and security of the treatment in short and long term. "
01/01/1988 - "Bopindolol in the treatment of moderate hypertension: a dose-response study."
01/01/1986 - "Dose-finding study with bopindolol in arterial hypertension."
01/01/1990 - "Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect."
12/01/1991 - "The results of this report suggest that bopindolol has a long lasting effect in the treatment of patients with chronic stable angina pectoris."
12/01/1991 - "Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action."
01/01/1990 - "Following a 4-week placebo period, 19 patients (12 male, average age 62.3 years) with chronic stable angina pectoris and a positive exercise test were treated with the beta-adrenoceptor antagonists bopindolol at increasing doses of 0.5, 1 and 2 mg, each being given once daily for 4 weeks. "
01/01/1991 - "In limited trials bopindolol has also successfully reduced symptoms in patients with angina pectoris, anxiety and essential tremor. "
|3.||Essential Tremor (Essential Tremors)
|4.||Cardiovascular Diseases (Cardiovascular Disease)
|5.||Coronary Artery Disease (Coronary Atherosclerosis)
01/01/1986 - "Effects of bopindolol on left ventricular function during exercise in patients with coronary artery disease."
12/01/1991 - "The effects of bopindolol, a new beta-adrenoceptor blocker, on the exercise tolerance of 12 in-patients, mean age 57 (5 years), with stable angina pectoris and documented coronary artery disease were evaluated. "
01/01/1990 - "Haemodynamic effects of bopindolol and atenolol in coronary artery disease. "
01/01/1990 - "Two patients on bopindolol left the study because of worsening symptoms of coronary artery disease, and two on atenolol owing to side effects, bradycardia and syncope in one and diarrhea in the other. "
|2.||Pindolol (LB 46)
|3.||7- O- (3- amino- 2,3,6- trideoxy- alpha- hexopyranosyl)- epsilon- isorhodomycinone (ATHR)